A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2023. Verfasst von Wakana Sato und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Protein Biosynthesis, Artificial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Aeronautics and Space Administration.
Abstract (Originalsprache)
Synthetic cells, expressing proteins using cell‐free transcription‐translation (TXTL), is a technology utilized for a variety of applications, such as investigating natural gene pathways, metabolic engineering, drug development or bioinformatics. For all these purposes, the ability to precisely control gene expression is essential. Various strategies to control gene expression in TXTL have been developed; however, further advancements on gene‐specific and straightforward regulation methods are still needed. Here, we present a method of control of gene expression in TXTL using a “silencing oligo”: a short oligonucleotide, designed with a particular secondary structure, that binds to the target messenger RNA. We demonstrated that silencing oligo inhibits protein expression in TXTL in a sequence‐dependent manner. We showed that silencing oligo activity is associated with RNase H activity in bacterial TXTL. To complete the gene expression control toolbox for synthetic cells, we also engineered a first transfection system. We demonstrated the transfection of various payloads, enabling the introduction of RNA and DNA of different lengths to synthetic cell liposomes. Finally, we combined the silencing oligo and the transfection technologies, demonstrating control of gene expression by transfecting silencing oligo into synthetic minimal cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Katarzyna P Adamala
Förderung
- National Aeronautics and Space Administration
Zitieren
APA
Sato, W., Rasmussen, M., Gaut, N., Devarajan, M., Stokes, K., Deich, C., Engelhart, A. E., & Adamala, K. P. (2023). A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28422
Vancouver
Sato W, Rasmussen M, Gaut N, Devarajan M, Stokes K, Deich C, et al. A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28422
BibTeX
@article{Sato2023,
author = {Sato, Wakana and Rasmussen, Melanie and Gaut, Nathaniel and Devarajan, Mahima and Stokes, Kaitlin and Deich, Christopher and Engelhart, Aaron E and Adamala, Katarzyna P},
title = {A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28422}
}
EUVIMED